Skip to main content

Table 1 Participant characteristics and use of non-steroidal anti-inflammatory medications, California Teachers Study, 2005–2012

From: Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

Characteristic

Number

Percentage

Age (years)a

 <40

1781

3.1

 40–49

7020

12.3

 50–59

16,651

29.1

 60–69

15,779

27.6

 70–79

10,482

18.3

 80–89

4812

8.4

  ≥ 90

639

1.1

Raceb

 White

50,250

87.9

 Hispanic

2220

3.9

 Asian/Pacific Islander

2135

3.7

 Black

1183

2.1

 Other/mixed

972

1.7

 Missing

404

0.7

Age at menarche (years)b

 <12

12,799

22.4

  ≥ 12

43,635

76.3

 Missing

730

1.3

Age at first full-term pregnancy (years)b

 Nulliparous

14,157

24.8

  < 25

15,171

26.5

  ≥ 25

26,909

47.1

 Missing

927

1.6

Total time breastfeeding (months)b

 Never or <12

40,567

71.0

  ≥ 12

15,446

27.0

 Missing

1,151

2.0

History of a benign breast biopsyb

 No

47,812

83.6

 Yes

9175

16.1

 Missing

177

0.3

Family history of breast cancer (mother or sister)b

 No

48,736

85.3

 Yes

6763

11.8

 Missing data or participant was adopted

1665

2.9

History of hospitalization for myocardial infarctionc

 No

56,586

99.0

 Yes

578

1.0

History of diabetes mellitusa

 No

54,433

95.2

 Yes

2715

4.8

 Missing

16

0.0

Strenuous plus moderate physical activity in the past 3 years (hours per week)a

 <3

26,079

45.6

 ≥3

30,909

54.1

 Missing

176

0.3

Alcohol consumption (grams per day)a

 None or <20

46,033

80.5

 ≥20

8652

15.1

 Missing

2479

4.3

Body mass index (kg/m2)a

 <25.0

29,509

51.6

 25.0–29.9

16,619

29.1

 ≥30.0

10,359

18.1

 Missing

677

1.2

Menopausal status and hormone therapy (HT) usea

 Premenopausal

6314

11.1

 Perimenopausal or postmenopausal

  

  No HT in the last 5 years

27,397

47.9

  Used HT in the last 5 years, but not currently using

10,142

17.7

  Current HT use

11,420

20.0

 Unknown menopausal status or HT use

1891

3.3

Regular-dose aspirin use at baselineb

 No NSAID used

37,075

64.9

 No regular-dose aspirin use, but used ibuprofen

7002

12.3

 Used 1–3 days/week

6340

11.1

 Used 4+ days/week

5732

10.0

 Unknown

1015

1.8

Low-dose aspirin use at the 10-year follow upa

 Never in the past 3 years

  No NSAID use in the past 3 yearse

21,421

37.5

  No low-dose aspirin use, use of 1+ type(s)

15,678

27.4

  No low-dose aspirin use, unknown use of 1+ type(s)

1829

3.2

 Former

2766

4.8

 Current, 1–2 tablets/week

915

1.6

 Current, 3–4 tablets/week

1163

2.0

 Current, 5–6 tablets/week

1406

2.5

 Current, 7+ tablets/week

10,421

18.2

 Unknown

1565

2.7

Regular-dose aspirin use at the 10-year follow upa

 Never in the past 3 years

  No NSAID use in the past 3 yearse

21,421

37.5

  No regular-dose aspirin use, use of 1+ type(s)

23,451

41.0

  No regular-dose aspirin use, unknown use for 1+ type(s)

2253

3.9

 Former/irregular

2378

4.2

 Current, 3+ tablets/week

6387

11.2

 Unknown

1274

2.2

Ibuprofen use at the 10-year follow upa

 Never in the past 3 years

  No NSAID use in the past 3 yearse

21,421

37.5

  No ibuprofen use, use of 1+ type(s)

18,219

31.9

  No ibuprofen use, unknown use for 1+ type(s)

1499

2.6

 Former/irregular

3679

6.4

 Current, 3+ tablets/week

10,382

18.2

 Unknown

1964

3.4

Other non-steroidal use at the 10-year follow upa

 Never in the past 3 years

  No NSAID use in the past 3 yearse

21,421

37.5

  No other non-steroidal use, use of 1+ type(s)

25,529

44.7

  No other non-steroidal use, unknown use for 1+ type(s)

2307

4.0

 Former/irregular

2301

4.0

 Current, 3+ tablets/week

4263

7.5

 Unknown

1343

2.4

Cox-2 inhibitor use at the 10-year follow upa

 Never in the past 3 yearse

  No NSAID use in the past 3 yearse

21,421

37.5

  No Cox-2 inhibitor use, use of 1+ type(s)

28,055

49.1

  No Cox-2 inhibitor use, unknown use for 1+ type(s)

2625

4.6

 Former/irregular

2807

4.9

 Current, 3+ tablets/week

1064

1.9

 Unknown

1192

2.1

  1. aFrom the 10-year follow-up questionnaire completed in 2005–2006. bFrom the baseline questionnaire completed in 1995–1996. cFrom linkage with the Office of Statewide Health Planning and Development (OSHPD) hospital discharge database from 1991 until the 10-year follow-up questionnaire. dIncluded aspirin and ibuprofen used regularly (at least once a week) reported on the baseline questionnaire. eIncluded aspirin, low-dose aspirin, ibuprofen, Cox-2 inhibitors, and other NSAIDs currently used regularly (at least once a week) reported on the 10-year follow-up questionnaire. NSAID non-steroidal anti-inflammatory drug